1,291.50
-1.50
(-0.12%)
At close: April 16 at 4:59:53 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
7,771,000
7,771,000
7,380,000
3,912,000
2,228,000
Investing Cash Flow
-9,907,000
-9,907,000
-1,282,000
-2,761,000
-961,000
Financing Cash Flow
-3,919,000
-3,919,000
-606,000
-789,000
-420,000
End Cash Position
9,858,000
9,858,000
14,867,000
9,893,000
8,957,000
Capital Expenditure
-304,000
-304,000
-376,000
-317,000
-252,000
Repayment of Debt
-60,000
-60,000
-91,000
-73,000
-58,000
Repurchase of Capital Stock
-3,879,000
-3,879,000
-564,000
-908,000
-447,000
Free Cash Flow
7,467,000
7,467,000
7,004,000
3,595,000
1,976,000
12/31/2021 - 10/20/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BAVA.CO Bavarian Nordic A/S
151.65
+0.43%
ZEAL.CO Zealand Pharma A/S
424.50
-4.61%
GUBRA.CO Gubra A/S
356.00
-4.30%
ALK-B.CO ALK-Abelló A/S
148.60
+1.36%
FLUO.ST FluoGuide A/S
38.00
-2.56%
YMAB Y-mAbs Therapeutics, Inc.
4.6900
+3.30%
BVNRY Bavarian Nordic A/S
7.58
+0.13%
ASND Ascendis Pharma A/S
165.05
+4.36%
EVAX Evaxion Biotech A/S
1.3090
+1.47%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
18.98
-2.16%